PeptiDream
PeptiDream Inc is a biopharmaceutical company, engaged in the research and development of new pharmaceutical candidates.
Launch date
Employees
Market cap
CAD3.4b
Enterprise valuation
CAD3.3b (Public information from Sep 2024)
Share price
JPY2565 4587.T
Tokyo Japan (HQ)
Financials
Estimates*
| JPY | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Revenues | 11.7b | 9.4b | 26.9b | 28.7b | 46.0b | 40.3b | 44.3b |
| % growth | - | (20 %) | 187 % | 7 % | 60 % | (12 %) | 10 % |
| EBITDA | 8.5b | 5.0b | 10.9b | 9.0b | 24.3b | 16.6b | 18.1b |
| % EBITDA margin | 73 % | 53 % | 41 % | 31 % | 53 % | 41 % | 41 % |
| Profit | 4.4b | 3.6b | 7.6b | 3.0b | 16.2b | 10.7b | 12.4b |
| % profit margin | 38 % | 39 % | 28 % | 11 % | 35 % | 26 % | 28 % |
| EV / revenue | 55.8x | 34.0x | 10.2x | 6.8x | 6.8x | 7.5x | 6.6x |
| EV / EBITDA | 76.5x | 63.7x | 25.1x | 21.6x | 12.9x | 18.2x | 16.2x |
| R&D budget | - | 1.7b | 2.9b | 3.2b | - | - | - |
| R&D % of revenue | - | 18 % | 11 % | 11 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Early VC | |
JPY299m | Late VC | ||
| N/A | N/A | IPO | |
| Total Funding | CAD3.1m | ||
